Massive patient registry launched to map silent liver disease epidemic
NCT ID NCT06123858
Summary
This study aimed to create a detailed picture of how non-alcoholic steatohepatitis (NASH), a serious form of fatty liver disease, is diagnosed and managed in China. Researchers planned to observe over 1,100 patients to collect real-world information on their symptoms, treatments, and healthcare use. The goal was to gather evidence to help improve future care guidelines and support the development of new treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASH WITH FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Beijing, China
-
Research Site
Changchun, China
-
Research Site
Chengdu, China
-
Research Site
Fuzhou, China
-
Research Site
Guangzhou, China
-
Research Site
Hangzhou, China
-
Research Site
Inner Mongolia, China
-
Research Site
Nanchang, China
-
Research Site
Qingdao, China
-
Research Site
Shanghai, China
-
Research Site
Shenyang, China
-
Research Site
Taiyuan, China
-
Research Site
Tianjin, China
-
Research Site
Wenzhou, China
-
Research Site
Xi'an, China
-
Research Site
Zhengzhou, China
Conditions
Explore the condition pages connected to this study.